home / stock / stss / stss articles

STSS Articles, Sharps Technology Inc. - From 09/29/23

Stock Information
Company Name: Sharps Technology Inc.
Stock Symbol: STSS
Market: NASDAQ
Website: sharpstechnology.com
Menu
STSS STSS Quote STSS Short STSS News STSS Articles STSS Message Board
Get STSS Alerts

News, Short Squeeze, Breakout and More Instantly...
Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement | Benzinga

NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company") (NASDAQ: "STSS" and "STSSW"), an innovative medical device ...
Crude Oil Rises Sharply; Know Labs Shares Plunge | Benzinga

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 200 points on Wednesday. The Dow traded down 0.69% to 33,3...

Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 152.8% to $1.09. The company announced the effective date for its reverse stock split after ...

Dow Falls Over 100 Points; US Durable Goods Orders Increase In August | Benzinga

U.S. stocks traded lower midway through trading, with the Dow Jones falling more than 100 points on Wednesday. The Dow traded down 0.40% to 33,484....
US Stocks Open Higher; Costco Posts Upbeat Earnings | Benzinga

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 50 points on Wednesday. Following the market opening Wednesday, th...

Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules | Benzinga

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company") (NASDAQ: "STSS" and "STSSW"), an innovative medical device ...

Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron Pharmaceuticals | Benzinga

$50 Million acquisition of InjectEZ strengthens manufacturing capacity and establishes Sharps' leading position in the specialized copolymer ...
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with ...

Previous 10 Next 10